Baxter International Inc.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infus…
Medical - Instruments & Supplies
US, Deerfield [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 18.16 | 49.88 | 42.21 | |
| Graham Fair Price | -61.75 | 5.13 | 13.42 | |
| PEG | -1357.92 | -1.75 | -0.12 | |
| Price/Book | 16.03 | 2.71 | 2.33 | |
| Price/Cash Flow | 2860.69 | -1701.80 | 57.48 | |
| Prices/Earnings | 647.39 | 149.48 | 20.00 | |
| Price/Sales | 22.08 | 6.16 | 5.05 | |
| Price/FCF | 2860.69 | -1701.80 | 57.48 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -0.95 | 0.38 | 0.38 | |
| Operating Margin | 9.14 | 0.09 | 0.08 | |
| ROA | -84.63 | < 0.005 | < 0.005 | |
| ROE | 0.03 | < 0.005 | -84.47 | |
| ROIC | < 0.005 | < 0.005 | 14.99 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.01 | -0.15 | 91.09 | |
| Dividends QOQ | 0.00 | < 0.005 | -100.00 | |
| EBIT QOQ | 7.45 | < 0.005 | -99.88 | |
| EPS QOQ | 1.67 | -0.85 | -48.74 | |
| FCF QOQ | 0.79 | -1.04 | 32.19 | |
| Revenue QOQ | 0.05 | -0.08 | 57.99 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Weak
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 105.33 | 119.84 | 13.78 | |
| Days Sales Outstanding (DSO) | 63.54 | 64.49 | 1.49 | |
| Inventory Turnover | 0.85 | 0.75 | -12.11 | |
| Debt/Capitalization | 0.63 | 0.63 | -0.66 | |
| Quick Ratio | 0.91 | 0.88 | -3.63 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Bad
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 16.57 | 16.09 | -2.92 | |
| Cash | 6.30 | 5.96 | -5.45 | |
| Capex | -0.37 | -0.35 | 7.55 | |
| Free Cash Flow | 0.67 | -0.03 | -96.20 | |
| Revenue | 7.66 | 7.07 | -7.72 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Bad
Fundamentals
Financial Health
06 - Financial Health ·
Weak